title: A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD.
abstract: BACKGROUND
  Currently, two methods for measuring TLC, RV, and FRC are used in clinical pulmonary function laboratories: body plethysmography and helium dilution. However, these methods are not interchangeable. In moderate-to-severe airflow obstruction, dilution method tends to underestimate and body plethysmography tends to overestimate RV.
  
  
  OBJECTIVE
  In 21 patients suffering from COPD (basal FEV(1): 56.69+/-13.64), we investigated whether the two methods of measuring FRC and RV could respond differently to a 2-week treatment with tiotropium 18 microg/day.
  
  
  RESULTS
  Tiotropium induced a significant increase in FEV(1) and FVC but not in IC. At baseline, FRC(pleth), RV(pleth) and TLC(pleth) were higher than FRC(He), RV(He) and TLC(He). At the end of the study FRC(pleth), RV(pleth) and TLC(pleth) decreased and FRC(He), RV(He) and TLC(He) increased but only changes in FRC(pleth) and RV(pleth) were statistically significant.
  
  
  CONCLUSIONS
  The use of body plethysmography seems to be more appropriate in clinical trials aimed at assessing the impact of a therapeutic procedure in patients with COPD and lung hyperinflation.
authors.affiliation: Unit of Respiratory Diseases, Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy. mario.cazzola@uniroma2.it
authors.forename: Mario
authors.initials: M
authors.lastname: Cazzola
authors.forename: Paola
authors.initials: P
authors.lastname: Rogliani
authors.forename: Giacomo
authors.initials: G
authors.lastname: Curradi
authors.forename: Andrea
authors.initials: A
authors.lastname: Segreti
authors.forename: Chiara
authors.initials: C
authors.lastname: Ciaprini
authors.forename: Gabriella
authors.initials: G
authors.lastname: Pezzuto
authors.forename: Cesare
authors.initials: C
authors.lastname: Saltini
mesh_terms: D000368:Aged; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D005260:Female; D005541:Forced Expiratory Volume / Q000502:physiology; D005652:Functional Residual Capacity; D006371:Helium; D006801:Humans; D008176:Lung Volume Measurements; D008297:Male; D010865:Pilot Projects; D010991:Plethysmography; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000503:physiopathology*; D012602:Scopolamine Derivatives / Q000627:therapeutic use; D000069447:Tiotropium Bromide; D014109:Total Lung Capacity / Q000502:physiology
chemical_list: D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D006371:Helium; D000069447:Tiotropium Bromide